Curated News
By: NewsRamp Editorial Staff
September 11, 2026
SS Innovations Brings Robotic Cardiac Surgery to Sri Lanka
TLDR
- SS Innovations expands into Sri Lanka with its first robotic cardiac program, pursuing FDA and CE clearance to outpace rivals.
- SS Innovations launched Sri Lanka's first robotic cardiac surgery program using the SSi Mantra 3.0 system, starting with a LIMA takedown.
- SS Innovations brings advanced robotic cardiac surgery to Sri Lanka, improving patient outcomes and expanding access to minimally invasive care.
- SS Innovations' SSi Mantra 3.0 system enabled Sri Lanka's first robotic cardiac surgery, with 25 procedures completed in three weeks.
Impact - Why it Matters
This news matters because it demonstrates the expanding global reach of robotic-assisted surgery, particularly in emerging markets where access to advanced cardiac care has been limited. The successful launch in Sri Lanka not only validates the SSi Mantra system’s capabilities but also signals a broader trend toward democratizing high-precision surgical interventions. For patients, this means less invasive procedures, potentially faster recovery times, and improved outcomes. For investors, the rapid procedure growth (143% year over year) and the pursuit of FDA clearance and CE marking indicate significant future revenue opportunities as SS Innovations scales into larger markets. As robotic surgery continues to evolve, SS Innovations is positioning itself as a key player in transforming surgical care worldwide.
Summary
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has helped launch Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo using the SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted left internal mammary artery (LIMA) takedown performed by Dr. Sudhir Srivastava, founder and chairman of SS Innovations, alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. This milestone procedure was highlighted in a recent company video, which also noted that Kings Hospital has completed more than 25 robotic procedures in just three weeks, underscoring the rapid adoption of the technology.
The company’s momentum extends beyond Sri Lanka. At the end of the second quarter, SS Innovations reported 224 cumulative SSi Mantra installations across 12 countries. Second-quarter revenue reached $13.9 million, while robotic procedures increased 143% year over year to 2,528, signaling rising utilization of the company’s installed base. The next major corporate milestone is regulatory expansion, with SS Innovations pursuing U.S. FDA clearance and European CE marking for the SSi Mantra system. For more details, Read More. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, SS Innovations Brings Robotic Cardiac Surgery to Sri Lanka
